Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
BJTRF's EV-to-EBITDA is ranked better than 77.54% of 739
companies
in the Drug Manufacturers industry
Industry Median: 13.2
vs BJTRF: 6.63
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Beijing Tong Ren Tang Chinese Medicine Co (OTCPK:BJTRF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Beijing Tong Ren Tang Chinese Medicine Co's PE Ratio (TTM) for today is calculated as:
Beijing Tong Ren Tang Chinese Medicine Co's share price for today is $0.6484.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Beijing Tong Ren Tang Chinese Medicine Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $0.060.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tong Ren Tang Chinese Medicine Co EV-to-EBITDA Chart
Beijing Tong Ren Tang Chinese Medicine Co Annual Data
For the Drug Manufacturers - Specialty & Generic subindustry, Beijing Tong Ren Tang Chinese Medicine Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Beijing Tong Ren Tang Chinese Medicine Co EV-to-EBITDA vs Drug Manufacturers Industry
Beijing Tong Ren Tang Chinese Medicine Co's current Enterprise Value is $431.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Beijing Tong Ren Tang Chinese Medicine Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $65.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) has a EV-to-EBITDA of 6.61 as of Aug. 24, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Beijing Tong Ren Tang Chinese Medicine Co. This is 29% below median its historical median of 9.33. Over the past decade, Beijing Tong Ren Tang Chinese Medicine Co's EV-to-EBITDA has ranged from 5.17 to 20.01. According to the industry distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #166 out of 739 companies in the Drug Manufacturers industry, placing it in the top 22.5%.
Is Beijing Tong Ren Tang Chinese Medicine Co's EV-to-EBITDA too high?
Beijing Tong Ren Tang Chinese Medicine Co's current EV-to-EBITDA of 6.61 is 29% below median its 10-year median of 9.33. Over the past 10 years, this metric has ranged from a low of 5.17 to a high of 20.01. The Drug Manufacturers industry median EV-to-EBITDA is 13.20. Beijing Tong Ren Tang Chinese Medicine Co's value of 6.61 is 49.9% below this industry median. Based on the distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #166 out of 739 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Beijing Tong Ren Tang Chinese Medicine Co has a GF Score™ of 88/100, reflecting its overall financial health beyond just this single metric.
How does Beijing Tong Ren Tang Chinese Medicine Co's EV-to-EBITDA compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Beijing Tong Ren Tang Chinese Medicine Co ranks #166 out of 739 companies for EV-to-EBITDA. This places Beijing Tong Ren Tang Chinese Medicine Co in the top 23% of its industry — outperforming the majority of peers. The industry median EV-to-EBITDA is 13.20. Beijing Tong Ren Tang Chinese Medicine Co's value of 6.61 is 49.9% below this benchmark. Historically, Beijing Tong Ren Tang Chinese Medicine Co's own EV-to-EBITDA has ranged from 5.17 to 20.01 over the past decade. While the company's 10-year median is 9.33 vs. the industry median of 13.20, Beijing Tong Ren Tang Chinese Medicine Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Drug Manufacturers company?
The median EV-to-EBITDA among Drug Manufacturers companies is 13.20, based on 739 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Beijing Tong Ren Tang Chinese Medicine Co's current EV-to-EBITDA of 6.61 is 49.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Beijing Tong Ren Tang Chinese Medicine Co. For the Drug Manufacturers industry, the median EV-to-EBITDA is 13.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Beijing Tong Ren Tang Chinese Medicine Co's current EV-to-EBITDA is 6.61, which is 29% below median its own 10-year median of 9.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Beijing Tong Ren Tang Chinese Medicine Co stock overvalued right now?
Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) has a current EV-to-EBITDA of 6.61. The stock's GF Value™ is $0.99, compared to a current price of $0.65 — trading 34.5% below its estimated fair value. The current EV-to-EBITDA is 6.61, which is 29% below median its 10-year median of 9.33 and 49.9% below the Drug Manufacturers industry median of 13.20. Beijing Tong Ren Tang Chinese Medicine Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Beijing Tong Ren Tang Chinese Medicine Co (BJTRF), the current EV-to-EBITDA is 6.61 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Beijing Tong Ren Tang Chinese Medicine Co (BJTRF) Overvalued in 2026?
Based on GuruFocus' analysis, Beijing Tong Ren Tang Chinese Medicine Co stock appears to be undervalued.
The current stock price of $0.65 is trading 34.5% below its estimated GF Value™ of $0.99.
Key valuation signals for BJTRF:
EV-to-EBITDA: 6.61 (29% below median its 10-year median of 9.33)
GF Value™: $0.99 vs. price of $0.65 (34.5% below fair value)
Industry Position: 49.9% below the Drug Manufacturers median (#166 of 739)
No single metric tells the full story. See the BJTRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Beijing Tong Ren Tang Chinese Medicine Co Ltd is a pharmaceutical retailer that specializes in Chinese medicine operating in three segments; Hong Kong includes the sale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments through retail and wholesale of Chinese medicine products and healthcare products; Chinese Mainland (PRC, but excluding Hong Kong, Macao, and Taiwan) includes wholesale of healthcare products in Chinese Mainland and the sole distributor of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd; and Overseas includes retail and wholesale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments.
88GF Score
Get the complete analysis for BJTRF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJTRF has been successfully added to your 
